Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement

Immunopharmacology

Volumn 49, Issue 1-2, 2000, Pages 149-157

  Pangburn, M K ^a  

^a UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

Alternative complement pathway; Complement regulatory proteins; Factor H; Innate immunity; SCR domains

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; REGULATOR PROTEIN;

COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; RECOGNITION; REVIEW; STREPTOCOCCUS PYOGENES; TRYPANOSOMA CRUZI; YERSINIA ENTEROCOLITICA;

EID: 0033921990     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)80300-8     Document Type: Conference Paper

References (91)

1. J. Alsenz J.D. Lambris T.F. Schulz M.P. Dierich Localization of the complement component C3b binding site and the cofactor activity for factor I in the 38 kDa tryptic fragment of factor H Biochem. J. 224 1984 389 398
2. J. Alsenz T.F. Schulz J.D. Lambris R.B. Sim M.P. Dierich Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H Biochem. J. 232 1985 841 850
3. J.P. Atkinson T.J. Oglesby D. White E.A. Adams M.K. Liszewski Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor Clin. Exp. Immunol. 86 1991 27 30
4. V.M. Avery D.L. Gordon Characterization of factor H binding to human polymorphonuclear leukocytes J. Immunol. 151 1993 5545 5553
5. T.K. Blackmore D.L. Gordon SCR 7 is a major heparin/sialic acid binding site of complement factor H Mol. Immunol. 33 1996 15
6. T.K. Blackmore V.A. Fischetti T.A. Sadlon H.M. Ward D.L. Gordon M protein of the group A streptococcus binds to the seventh short consensus repeat of human complement factor H Infect. Immun. 66 1998 1427 1436
7. T.K. Blackmore J. Hellwage T.A. Sadlon N. Higgs P.F. Zipfel H.M. Ward D.L. Gordon Identification of the second heparin-binding domain in human complement factor H J. Immunol 160 1998 3342 3348
8. M.C. Carroll The role of complement and complement receptors in induction and regulation of immunity Annu. Rev. Immunol. 16 1998 545 568
9. B. China M.P. Sory B.T. N'Guyen M. De Bruyere G.R. Cornelis Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules Infect. Immun. 61 1993 3129 3136
10. N.R. Cooper Complement evasion strategies of microorganisms Immunol. Today 12 1991 327 331
11. J. Dawes Interactions of heparins in the vascular environment Haemostasis 23 1993 212 219
12. R.G. Discipio Ultrastructures and interactions of complement factors H and I J. Immunol. 149 1992 2592 2599
13. 2 (CD11b/CD18) J. Immunol. 160 1998 4057 4066
14. W.J. Ellis B.A. Blumenstein L.M. Ishak D.L. Enfield Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors Urology 50 1997 882 887
15. A. Erdei R.B. Sim Complement factor H-binding protein of Raji cells and tonsil B lymphocytes Biochem. J. 246 1987 149 156
16. D.T. Fearon Regulation by membrane sialic acid of βIH-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway Proc. Natl. Acad. Sci. U. S. A. 75 1978 1971 1975
17. D.T. Fearon Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane Proc. Natl. Acad. Sci. U. S. A. 76 1979 5867 5871
18. D.T. Fearon Seeking wisdom in innate immunity Nature 388 1997 323 324
19. D.T. Fearon K.F. Austen Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms Proc. Natl. Acad. Sci. U. S. A. 74 1977 1683 1687
20. D.T. Fearon K.F. Austen Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins J. Exp. Med. 146 1977 22 33
21. D.T. Fearon R.M. Locksley The instructive role of innate immunity in the acquired immune response Science 272 1996 50 54
22. V.A. Fischetti Streptococcal M protein Sci. Am. 264 1991 58 65
23. V.A. Fischetti R.D. Horstmann V. Pancholi Location of the complement factor H binding site on Streptococcal M6 protein Infect. Immun. 63 1995 149 153
24. D.L. Gordon R.M. Kaufman T.K. Blackmore J. Kwong D.M. Lublin Identification of complement regulatory domains in human factor H J. Immunol. 155 1995 348 356
25. R.A. Harrison P.J. Lachmann Complement technology D.M. Weir Handbook of Experimental Immunology 1986 Blackwell NY 39.1 39.49
26. R.L. Hirsch D.E. Griffin J.A. Winkelstein Natural immunity to Sindbis virus is influenced by host tissue sialic acid content Proc. Natl. Acad. Sci. U. S. A. 80 1983 548 550
27. J.A. Hoffmann F.C. Kafatos C.A. Janeway Jr. R.A.B. Ezekowitz Phylogenetic perspectives in innate immunity Science 284 1999 1313 1318
28. K. Hogasen J.H. Jansen T.E. Mollnes J. Hovdenes M. Harboe Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency J. Clin. Invest. 95 1995 1054
29. R.D. Horstmann Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation Infect. Immun. 60 1992 721 727
30. R.D. Horstmann M.K. Pangburn H.J. Müller-Eberhard Species specificity of recognition by the alternative pathway of complement J. Immunol. 134 1985 1101 1104
31. R.D. Horstmann H.J. Sievertsen J. Knobloch V.A. Fischetti Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H Proc. Natl. Acad. Sci. U. S. A. 85 1988 1657 1661
32. H. Jarva T.S. Jokiranta J. Hellwage P.F. Zipfel S. Meri Regulation of complement activation by C-reactive protein:targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8–11 J. Immunol. 163 1999 3957 3962
33. G.A. Jarvis N.A. Vedros Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation Infect. Immun. 55 1987 174 180
34. A.A. Johnson A.M. Rosengard K. Skjodt J.M. Ahearn R.G.Q. Leslie The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras Eur. J. Immunol. 29 1999 3837 3844
35. K.A. Joiner Complement evasion by bacteria and parasites Annu. Rev. Microbiol. 42 1988 201 230
36. T.S. Jokiranta J. Hellwage V. Koistinen P.F. Zipfel S. Meri Each of the three binding sites on factor H interacts with a distinct site on C3b Mol. Immunol. 35 1998 360
37. M.-H. Jouvin M.D. Kazatchkine A. Cahour N. Bernard Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement J. Immunol. 133 1984 3250 3254
38. R. Kinders T. Jones R. Root C. Bruce H. Murchison M. Corey L. Williams D.L. Enfield G.M. Hass Complement factor H or a related protein is a marker for transitional cell cancer of the bladder Clin. Cancer Res. 4 1998 2511 2520
39. H. Kotarsky J. Hellwage E. Johnson C. Skerka H.G. Svensson G. Lindahl U. Sjobring P.F. Zipfel Identification of a domain in human factor H and factor H-like protein-l required for the interaction with streptococcal M proteins J. Immunol. 160 1998 3349
40. T.R. Kozel M.A. Wilson W.H. Welch Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans Infect. Immun. 60 1992 3122 3127
41. T. Kristensen B.F. Tack Murine protein H is comprised of 20 repeating units, 61 amino acids in length Proc. Natl. Acad. Sci. U. S. A. 83 1986 3963 3967
42. S. Kühn C. Skerka P.F. Zipfel Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H J. Immunol. 155 1995 5663 5670
43. J.D. Lambris G.D. Ross Characterization of the lymphocyte membrane receptor for factor H with an antibody to anti-factor H idiotype J. Exp. Med. 155 1982 1400 1411
44. J.D. Lambris D. Avila J.D. Becherer H.J. Müller-Eberhard A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides J. Biol. Chem. 263 1988 12147 12150
45. M. Levy L. Halbwachs-Mecarelli M.C. Gubler G. Kohout A. Bensenouci P. Niadet G. Hauptmann P. Lesavre H deficiency in two brothers with atypical dense intramembranous disease Kidney Int. 30 1986 949
46. M.K. Liszewski T.C. Farries D.M. Lublin I.A. Rooney J.P. Atkinson Control of the complement system Adv. Immunol. 61 1996 201 283
47. D.M. Lublin J.P. Atkinson Decay-accelerating factor and membrane cofactor protein Curr. Top. Microbiol. Immunol. 153 1990 123 145
48. S. Meri M.K. Pangburn Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H Proc. Natl. Acad. Sci. U. S. A. 87 1990 3982 3986
49. C. Mold G.R. Nemerow B.M. Bradt N.R. Cooper CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by raji cells J. Immunol. 140 1988 1923 1929
50. C. Mold H. Gewurz T.W. Du Clos Regulation of complement activation by C-reactive protein Immunopharmacology 42 1999 23 30
51. T.E. Mollnes J. Riesenfeld P. Garred E. Nordstrom K. Hogasen E. Fosse O. Götze M. Harboe A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin Artif. Organs 19 1995 909 917
52. M.D. Moore R.G. Discipio N.R. Cooper G.R. Nemerow Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein—Barr virus/C3dg receptor (CR2) J. Biol. Chem. 264 1989 20576 20582
53. A. Nicholson-Weller J. Burge D.T. Fearon P.F. Weller K.F. Austen Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system J. Immunol. 129 1982 184 189
54. M.K. Pangburn Initiation and activation of the alternative pathway of complement E.R. Podack Cytolytic Lymphocytes and Complement: Effectors of the Immune System 1988 CRC Press Boca Raton, FL 41 56
55. M.K. Pangburn The alternative pathway: activation and regulation K. Rother G.O. Till The Complement System 1998 Springer NY 93 115
56. M.K. Pangburn H.J. Müller-Eberhard Complement C3 convertase: cell surface restriction of βIH control and generation of restriction on neuraminidase treated cells Proc. Natl. Acad. Sci. U. S. A. 75 1978 2416 2420
57. M.K. Pangburn H.J. Müller-Eberhard The alternative pathway of complement Springer Semin. Immunopathol. 7 1984 163 192
58. M.K. Pangburn H.J. Müller-Eberhard The C3 convertase of the alternative pathway of human complement. Enzymatic properties of the biomolecular proteinase Biochem. J. 235 1986 723 730
59. M.K. Pangburn R.D. Schreiber H.J. Müller-Eberhard Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein βIH for cleavage of C3b and C4b in solution J. Exp. Med. 146 1977 257 270
60. M.K. Pangburn M.A.L. Atkinson S. Meri Localization of the heparin-binding site on complement factor H J. Biol. Chem. 266 1991 16847 16853
61. M.K. Pangburn K.L.W. Pangburn V. Koistinen S. Meri A.K. Sharma Molecular mechanisms of target recognition in an innate immune system: interactions between factor H, C3b and target in the alternative pathway of complement J. Immunol 2000 in press
62. S.J. Perkins A.S. Nealis R.B. Sim Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering Biochemistry 30 1991 2847 2857
63. V. Pichette S. Querin W. Schurch G. Brun G. Lehner-Netsch J.M. Delage Familial hemolytic-uremic syndrome and homozygous factor H deficiency Am. J. Kidney Dis. 24 1994 936 943
64. C. Pinter A.G. Siccardi L. Lopalco R. Longhi A. Clivio HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology AIDS Res. Hum. Retroviruses 11 1995 971
65. S. Ram A.K. Sharma S.D. Simpson S. Gulati D.P. McQuillen M.K. Pangburn P.A. Rice A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae J. Exp. Med. 187 1998 743 752
66. S. Ram D.P. McQuillen S. Gulati W.J. Ellis M.K. Pangburn P.A. Rice Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae J. Exp. Med. 188 1998 671 680
67. J. Ripoche A.J. Day T.J.R. Harris R.B. Sim The complete amino acid sequence of human complement factor H Biochem. J. 249 1988 593 602
68. R.D. Schreiber M.K. Pangburn R.G. Medicus H.J. Müller-Eberhard Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement Clin. Immunol. Immunopathol 15 1980 384 396
69. T. Seya J.R. Turner J.P. Atkinson Purification and characterization of a membrane protein (gp45–70) that is a cofactor for cleavage of C3b and C4b J. Exp. Med. 163 1986 837 855
70. A.K. Sharma M.K. Pangburn Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis Proc. Natl. Acad. Sci. U. S. A. 93 1996 10996 11001
71. A.K. Sharma M.K. Pangburn Localization by site-directed mutagenesis of the site in human complement factor H that binds to Streptococcus pyogenes M protein Infect. Immun. 65 1997 484 487
72. R.B. Sim R.G. Discipio Purification and structural studies on the complement system control protein βIH (factor H) Biochem. J. 205 1982 285 293
73. R.B. Sim S.J. Perkins Molecular modelling of C3 and its ligands Curr. Top. Microbiol. 153 1989 209 222
74. C. Skerka J. Hellwage W. Weber A. Tilkorn F. Buck T. Marti E. Kampen U. Beisiegel P.F. Zipfel The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins J. Biol. Chem. 272 1997 5627 5634
75. H. Smith J.A. Cole N.J. Parsons The sialylation of gonococcal lipopolysaccharide by host factors: a major impact on pathogenicity FEMS Microbiol. Lett. 79 1992 287 292
76. L.C. Smith K. Azumi M. Nonaka Complement systems in invertebrates. The ancient alternative and lectin pathways Immunopharmacology 42 1999 107 120
77. P. Stevens S.N.Y. Huang W.D. Welch L.S. Young Restricted complement activation by Escherichia coli with K-l capsular serotype: a possible role in pathogenicity J. Immunol. 121 1978 1216 1217
78. H. Stoiber C. Pinter A.G. Siccardi A. Clivio M.P. Dierich Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAFCD55) J. Exp. Med. 183 1996 307
79. S. Tomlinson L.C. Pontes de Carvalho F. Vandekerckhove V. Nussenzweig Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement J. Immunol. 153 1994 3141
80. J.M. Weiler M.R. Daha K.F. Austen D.T. Fearon Control of the amplification convertase of complement by the plasma protein βIH Proc. Natl. Acad. Sci. U. S. A. 73 1976 3268 3272
81. H.F. Weisman T. Bartow M.K. Leppo H.C. Marsh G.R. Carson M.F. Concino M.P. Boyle K.H. Roux M.L. Weisfeldt D.T. Fearon Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis Science 249 1990 146 151
82. M.R. Wessels C.E. Rubens V.-J. Benedi D.L. Kasper Definition of a bacterial virulence factor: sialylation of the group B streptoccal capsule Proc. Natl. Acad. Sci. U. S. A. 86 1989 8983 8987
83. C.D. West A.J. McAdams The alternative pathway C3 convertase and glomerular deposits Pediatr. Nephrol. 13 1999 448 453
84. L.M. Wetzler K. Barry M.S. Blake E.G. Gotschlich Gonococcal lipopolysaccharide sialylation prevents complement-dependent killing by immune sera Infect. Immun. 60 1992 39 43
85. K. Whaley S. Ruddy Modulation of the alternative complement pathway by βIH globulin J. Exp. Med. 144 1976 1147 1163
86. R. Wurzner Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry Mol. Immunol. 36 1999 249 260
87. L. Ying Y. Katz M. Schlesinger R. Carmi H. Shalev N. Haider G. Beck V.C. Sheffield D. Landau Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome Am. J. Hum. Genet. 65 1999 1538 1546
88. B.J. Young T.R. Kozel Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans Infect. Immun. 61 1993 2966 2972
89. P.F. Zipfel C. Skerka Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today 15 1994 121 126
90. P.P. Zipfel T.S. Jokiranta J. Hellwage V. Koistinen S. Meri The factor H protein family Immunopharmacology 42 1999 53 60
91. P.F. Zipfel J. Hellwage M.A. Friese G Hegasy T.S. Jokiranta S. Meri Factor H and disease: a complement regulator affects vital body functions Mol. Immunol. 36 1999 241 248